Comparative Effects of Stimulant and Antipsychotic Medications on Eating Behaviors and Weight in Children with Attention Deficit Hyperactivity Disorder

Basit Öğe Kaydı
dc.authoridAykutlu, Hasan Cem/0000-0002-4809-4857
dc.authoridKARADAG, MEHMET/0000-0002-4130-0494
dc.authoridOzturk, Masum/0000-0002-9989-7051
dc.contributor.authorAykutlu, Hasan Cem
dc.contributor.authorOkyar, Esra
dc.contributor.authorKaradag, Mehmet
dc.contributor.authorOzturk, Masum
dc.date.accessioned2025-02-22T14:08:40Z
dc.date.available2025-02-22T14:08:40Z
dc.date.issued2024
dc.departmentDicle Üniversitesien_US
dc.description.abstractBackground/Objectives: Attention-Deficit/Hyperactivity Disorder (ADHD) is associated with an increased risk of obesity and disordered eating behaviors. This study compared weight status and eating behaviors among drug-na & iuml;ve ADHD children, those on stimulant monotherapy, those on combined stimulant and antipsychotic treatment, and healthy controls. Methods: This cross-sectional study included 547 children aged 6-12 years from four Turkish provinces: 361 with ADHD (152 drug-na & iuml;ve, 156 on stimulants, and 53 on combined therapy), and 186 healthy controls. Anthropometric measurements, psychiatric assessments, and eating behavior evaluations were conducted using standardized tools. Results: Drug-na & iuml;ve ADHD children had the highest obesity rate (13.8%), while those on stimulant monotherapy had the lowest (4.5%) compared to controls. Combined treatment group obesity rates were similar to controls (7.5% vs. 8.6%). The drug-na & iuml;ve and combined treatment groups showed increased food approach behavior and desire to drink, with the combined treatment group also showing increased emotional overeating. Conclusions: This study reveals a complex relationship between ADHD, its pharmacological management, and the risk of obesity. Stimulant monotherapy may mitigate the risk of obesity, while combined stimulant and antipsychotic treatment may lead to problematic eating behaviors. These findings emphasize the importance of monitoring weight status and eating behaviors in ADHD children, especially those receiving pharmacological interventions.en_US
dc.identifier.doi10.3390/children11101189
dc.identifier.issn2227-9067
dc.identifier.issue10en_US
dc.identifier.pmid39457154en_US
dc.identifier.scopus2-s2.0-85207704815en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.urihttps://doi.org/10.3390/children11101189
dc.identifier.urihttps://hdl.handle.net/11468/29562
dc.identifier.volume11en_US
dc.identifier.wosWOS:001343150600001
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherMdpien_US
dc.relation.ispartofChildren-Baselen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmzKA_WOS_20250222
dc.subjectattention deficit disorder with hyperactivityen_US
dc.subjectobesityen_US
dc.subjectfeeding and eating disordersen_US
dc.subjectchilden_US
dc.subjectcentral nervous system stimulantsen_US
dc.subjectantipsychotic agentsen_US
dc.subjectbody weighten_US
dc.subjecteating behavioren_US
dc.subjectcross-sectional studiesen_US
dc.subjectdrug therapyen_US
dc.subjectcombinationen_US
dc.titleComparative Effects of Stimulant and Antipsychotic Medications on Eating Behaviors and Weight in Children with Attention Deficit Hyperactivity Disorderen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu